A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Lorlatinib Impurity 14 | CAS 2857871-86-2 - Request Quote

Picture of Lorlatinib Impurity 14

Lorlatinib Impurity 14

SZ CAT No:SZ-L054019
CAS No
2857871-86-2
Mol.F.
C26H30FN7O2
Mol.Wt.
491.6
Inv. Status
Synthesis on demand

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Lorlatinib Impurity 14 is chemically . Lorlatinib Impurity 14 is supplied with detailed characterization data compliant with regulatory guideline. Lorlatinib Impurity 14 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lorlatinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 2857871-86-2

Purchase 2857871-86-2

Order 2857871-86-2

Enquire 2857871-86-2

price of 2857871-86-2

2857871-86-2 Supplier

2857871-86-2 Manufacturer

2857871-86-2 Exporter

buy high quality Lorlatinib Impurity 14

Purchase Lorlatinib Impurity 14

Lorlatinib Impurity 14 suppliers

Lorlatinib Impurity 14 manufacturers

Lorlatinib Impurity 14 price

Order Lorlatinib Impurity 14

Enquire Lorlatinib Impurity 14

Lorlatinib Impurity 14 cost

Lorlatinib Impurity 14 Supplier

Lorlatinib Impurity 14 Distributor

Lorlatinib Impurity 14 for Method Validation

Lorlatinib Reference Standard

Lorlatinib Impurity 14 for ANDA Filing

Lorlatinib Impurity 14 for Forced Degradation Studies

Lorlatinib Impurity 14 Identification Standards

Lorlatinib Impurity 14 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,